a d lh-rh

Modify Date: 2024-04-05 14:50:36

a d lh-rh Structure
a d lh-rh structure
Common Name a d lh-rh
CAS Number 54784-44-0 Molecular Weight 1206.35000
Density 1.46g/cm3 Boiling Point N/A
Molecular Formula C59H79N15O13 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of a d lh-rh


[D-Phe2,D-Ala6]-LH-RH is a potent LH-RH antagonist. [D-Phe2,D-Ala6]-LH-RH shows anti-LH/FSH-RH and antiovulatory activities[1].

 Names

Name a d lh-rh
Synonym More Synonyms

 a d lh-rh Biological Activity

Description [D-Phe2,D-Ala6]-LH-RH is a potent LH-RH antagonist. [D-Phe2,D-Ala6]-LH-RH shows anti-LH/FSH-RH and antiovulatory activities[1].
Related Catalog
In Vivo [D-Phe2,D-Ala6]-LH-RH inhibits the LH and FSH release induced by LH-RH in immature male rats[1]. [D-Phe2,D-Ala6]-LH-RH (1 mg/rat, SC) shows marked antiovulatory and contraceptive activity[2].[D-Phe2,D-Ala6]-LH-RH (0.625, 1.25, 2.5 mg/kg; s.c.; single dose; sacrificed 30 minutes) results a dose-dependent increase in stalk-median eminence (SME)-LHRH activity and decreases plasma LHRH activity as well in rats with hypophysectomized (hypox) at 25 days old[3]. [D-Phe2,D-Ala6]-LH-RH (25 mg/kg; s.c.; single dsoe) is effective in blocking the ovulation normally induced by LRH alone[4]. Animal Model: Adult female Sprague-Dawley rats (200-250 g)[2] Dosage: 1 mg/rat Administration: SC injections, from 12:00 to 14:30 hr on the day of proestrus Result: Showed marked antiovulatory and contraceptive activity, with 96% inhibition of ovulation.
References

[1]. Vilchez-Martinez JA, et al. Comparison of the anti-LH/FSH-RH and anti-ovulatory activities of (D-Phe2, D-Leu6)-LH-RH and (D-Phe2, D-Ala6)-LH-RH. Endocr Res Commun. 1976;3(3-4):231-41.

[2]. Beattie CW, et al. Luteinizing hormone-releasing hormone. Antiovulatory activity of analogs substituted in positions 2 and 6. J Med Chem. 1975 Dec;18(12):1247-50.

[3]. Corbin A, et al. Effect of luteinizing hormone releasing hormone (LHRH) and an LHRH antagonist of hypothalamic and plasma LHRH of hypophysectomized rats. Endocrinology. 1976 Jan;98(1):247-50.

[4]. Corbin A, et al. Ihibition of the pre-ovulatory proestrous gonadotropin surge, ovulation and pregnancy with a peptide analogue of luteinizing hormone releasing hormone. Endocr Res Commun. 1975;2(1):1-23.

 Chemical & Physical Properties

Density 1.46g/cm3
Molecular Formula C59H79N15O13
Molecular Weight 1206.35000
Exact Mass 1205.60000
PSA 443.45000
LogP 2.77280
Index of Refraction 1.687

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
OK6600000
CHEMICAL NAME :
Luteinizing hormone-releasing hormone, (D-phe(sup 2))-(D-ala(sup 6))-
CAS REGISTRY NUMBER :
54784-44-0
LAST UPDATED :
198910
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C59-H79-N15-O13
MOLECULAR WEIGHT :
1206.53

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
3750 ug/kg
SEX/DURATION :
female 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - other measures of fertility
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 18,1247,1975
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
2500 ug/kg
SEX/DURATION :
female 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - female fertility index (e.g. # females pregnant per # sperm positive females; # females pregnant per # females mated)
REFERENCE :
IJGOAL International Journal of Gynaecology & Obstetrics. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.7- 1969- Volume(issue)/page/year: 16,359,1979
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
30 mg/kg
SEX/DURATION :
female 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - other measures of fertility
REFERENCE :
EDRCAM Endocrine Research Communcations. (New York, NY) V.1-9, 1974-83. Volume(issue)/page/year: 2,1,1975
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
12500 ug/kg
SEX/DURATION :
female 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - other measures of fertility
REFERENCE :
EDRCAM Endocrine Research Communcations. (New York, NY) V.1-9, 1974-83. Volume(issue)/page/year: 2,1,1975

 Safety Information

Risk Phrases 60
Safety Phrases 53-22-36/37/39-45

 Synonyms

GLP-DPHE-TRP-SER-TYR-DALA-LEU-ARG-PRO-GLY-NH2
[D-PHE2,D-ALA6]-LH-RH (HUMAN)
PYR-D-PHE-TRP-SER-TYR-D-ALA-LEU-ARG-PRO-GLY-NH2
[D-PHE2,D-ALA6]-LH-RH
PGLU-D-PHE-TRP-SER-TYR-D-ALA-LEU-ARG-PRO-GLY-NH2
D-phe2,D-ala6-luteinizing hormone*releasing hormo
wy-18,185
LHRH,Phe(2)-Ala(6)
(d-phe(sup2))-(d-ala(sup6))-lhrh
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

a d lh-rh suppliers

a d lh-rh price

Related Compounds: More...
a-D-Glucopyranoside,methyl 6-chloro-6-deoxy-
4144-87-0
A-D-GLUCOPYRANOSIDE,METHYL2-DEOXY-2-[[(PHENYLMETHOXY)CARBONYL]AMINO]-3-O-(PHENYLMETHYL)-,6-ACETATE
114869-95-3
a-D-Galactopyranoside, methyl4,6-O-(phenylmethylene)-, dibenzoate (9CI)
6953-72-6
a-D-Glucofuranose,1,2-O-(1-methylethylidene)-, tribenzoate (9CI)
6339-03-3
a-D-Glucopyranosylazide
20379-60-6
a-D-Glucofuranose,1,2:5,6-bis-O-(1-methylethylidene)-, dimethylcarbamothioate (9CI)
16713-76-1
a-D-Xylofuranose,5-deoxy-3-O-methyl-1,2-O-(1-methylethylidene)-5-(methyloxidoimino)-
37797-42-5
a-D-Arabinopyranoside, methyl
3867-83-2
a-D-Glucopyranoside,6-deoxy-6-fluoro-b-D-fructofuranosyl6-deoxy-6-fluoro-
76410-46-3
(9H-fluoren-9-yl)methyl N-[(5-amino-3-iodo-2-methylphenyl)methyl]carbamate
2418708-13-9
(9H-fluoren-9-yl)methyl N-[(3-amino-5-iodo-4-methylphenyl)methyl]carbamate
2418682-80-9
(9H-fluoren-9-yl)methyl N-[3-(aminomethyl)-5-iodo-4-methylphenyl]carbamate
2418715-98-5
N-[1-(aminomethyl)cyclohexyl]-3-(acetamidomethyl)benzamide hydrochloride
2418716-29-5
N-({3-[4-(aminomethyl)-1H-1,2,3-triazol-1-yl]phenyl}methyl)-6-methyl-2,3-dihydro-1-benzothiophene-2-carboxamide
2418659-68-2
N-[[3-[4-(aminomethyl)triazol-1-yl]phenyl]methyl]-6-methyl-2,3-dihydro-1-benzothiophene-2-carboxamide;hydrochloride
2418691-57-1
2-[2-[(3S,4R)-3-amino-4-(4-methoxyphenyl)pyrrolidin-1-yl]-2-oxoethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride
2418595-19-2
N-(Phenylmethyl)-N-[(1,2,3,4-tetrahydro-1-oxo-2-naphthalenyl)methyl]benzamide
79610-47-2
2-({[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-(2-methoxy-2-oxoethyl)-4-methylphenyl]methyl}amino)acetic acid
2418716-50-2
2-({[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-(2-methoxy-2-oxoethyl)-2-methylphenyl]methyl}amino)acetic acid
2418727-41-8